Association of lung function by spirometry with serum ferritin in transfusion-dependent thalassemia patients in a tertiary care centre
DOI:
https://doi.org/10.18203/2349-3291.ijcp20232584Keywords:
β-thalassemia, Ferritin, Pulmonary functionAbstract
Background: β-thalassemia major is an inherited, transfusion-dependent chronic anemia which is caused by decreased production of β-globin chains required for formation of hemoglobin. Regular blood transfusion is most important factors that help in improving the survival of patients with TM; however, it leads to iron deposition in many organs such as lung. Most studied concerned about effect of iron on lung functions, revealed abnormalities, but limited data were observed. The aim of our study was to determine pulmonary function abnormalities in children with thalassemia major and assess the relation between these abnormalities and iron overload.
Methods: This study had included 51 children in each group, aged between 6 and 18 years (28 males and 23 females) with TM. All included children were subjected to full clinical examination and laboratory investigations including complete blood counts and serum ferritin. Pulmonary function tests (PFTs) were assessed in all included children using spirometry.
Results: 31.4% patients had restrictive lung functions. Spirometer parameters i.e., FEF25-75% (p value≤0.0001) and PEFR (%pred) (p value≤0.0001) had significant difference in both groups. FEF25-75% and PEFR had no effect of serum ferritin.
Conclusions: The lung may be considered a site for organ damage, and alteration of pulmonary function may be expected in transfusion-dependent patients in spite of no pulmonary symptoms or normal chest X-ray.
Metrics
References
Cooley TB, Lee P. A series of cases of splenomegaly inchildren with anemia and peculiar bone changes. Trans. Am Pediatr Soc. 1925;37:29.
Ingram VM, Stretton AOW. Genetic basis of the thalassemia diseases. Nature. 1959;184:1903.
Kan YW, Nathan DG. Mild thalassemia: the result of interactions of alpha and beta thalassemia gen. J Clin Invest. 1970;49:635.
Dameshek W. Target cell’ anemia. An erythroblastic type of Cooley’sery throblastic anemia. Am J Med Sci. 1940;200:445.
Sephton SR. Iron excretionin thalassaemia major after administration of chelating agents. Br Med J. 1962;2:1577.
Grinstein M, Bannerman RM, Vavra JD, Moore CV. Hemoglobin metabolism in thalassemia. Am J Med. 1960;29:18.
Sturgeon P, Finch CA. Erythrokinetics in Cooley’s anemia. Blood. 1957;12:64.
Erlandson ME, Schulman I, Stern G, Smith CH. Studies of congenital hemolytic syndromes. I. Rates of destruction and production of erythrocytesin thalassemia. Pediatr. 1962;22:910.
Erlandson ME, Golubow J, Wehman J, Smith CH. Metabolism of iron, calcium and magnesium in homozygous thalassemia. Ann NY Acad Sci. 1970; 119,769.
Cavill I, Ricketts C, Jacobs A. et al. Erythropoiesis and the effect of transfusion in homozygous beta thalassemia. N Eng J Med. 1972;298:776.
Bailey IS, Prankerd TAJ. Studies in thalassaemia. Br J Haematol. 1958;4:150.
Shinar E, Shalev O, Rachmilewitz EA, Schrier SL. Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood. 1987;70(1):158-64.
Schrier SL, Rachmilewitz E, Mohandas N. Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: implication for differences in clinical manifestations. Blood. 1989;74(6):2194-202.
Advani R, Sorenson S, Shinar E, Lande W, Rachmilewitz E, Schrier SL. Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia. Blood. 1992;79(4):1058-63.
Blendis LM, Modell CB, Bowdler AJ, Williams R. Some effects of splenectomy in thalassaemia major. Br J ¬¬¬¬Haematol. 1974;28:77.
Downloads
Published
How to Cite
Issue
Section
